Could a single pill ease pain after bariatric surgery?
NCT ID NCT07169006
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a single dose of gabapentin, given before weight-loss surgery, can reduce pain and the need for other painkillers in the first 24 hours after the operation. About 102 people having bariatric surgery will receive either gabapentin or a placebo. The goal is to see if this simple approach improves recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- gabapentin
- What this could lead to
- If it works, this could point toward a simple, low-cost way to improve pain control after weight-loss surgery.
- What could go wrong
- This is a small, early-stage trial with only 102 participants. The results may not apply to all patients, and gabapentin can cause side effects like dizziness or drowsiness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 102 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * patients with American Society of Anesthesiologists physical status ASA I to III * both genders * Morbid obese scheduled for bariatric surgery Exclusion Criteria: * patients with impaired liver or kidney disease * patients with history of hypersensitivity to gabapentin * patients with history of alcohol abuse, chronic pain or frequent use of analgesic * patients with uncontrolled medical disease
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bariatric surgery analgesia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why do some people with severe obesity develop kidney disease?
- Can cooking classes curb dangerous pregnancy weight gain?
- Can tailoring bypass length to the individual improve Weight-Loss surgery?
- Can shedding pounds reshape the legs? a study tracks joint alignment after Weight-Loss surgery
- Can shedding weight reshape the spine? a study tracks the changes
- Could belly fat age our cells faster?